Larvol Delta - MyMD-Pharmaceuticals-to-Present-Updated-Statistically-Signicant-Phase-2-Data-for-MYMD1-Potential-TNF-Market-Disrupter-at-BioFuture-2023

isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci

https://www.businesswire.com/news/home/20231004139695/en/MyMD-Pharmaceuticals-to-Present-Updated-Statistically-Significant-Phase-2-Data-for-MYMD-1-Potential-TNF-%CE%B1-Market-Disrupter-at-BioFuture-2023

Oct 4, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next